This study aims to understand how often women experience post-traumatic stress disorder (PTSD) after receiving intracavitary brachytherapy (a type of radiation therapy where a radioactive source is placed inside the body) for gynecologic cancer. Researchers will also look at how factors like pain during implant removal, anxiety, depression, quality of life, and the use of propofol (a medicine used for sedation) might be connected to PTSD and acute stress disorder (ASD). This is an observational study, meaning participants will be monitored without receiving a specific intervention from the study. The study plans to enroll 36 women aged 18 or older who have had multiple intracavitary brachytherapy treatments for gynecologic cancer and can complete surveys. The study's success will be measured by tracking safety and any side effects. The current recruitment status is unclear.

Study design

This is an observational study that plans to include 36 participants. It is not specified if it is randomized or blinded.

What's involved

You would need to complete patient surveys multiple times throughout and after your treatment.

Compensation

Not stated in the trial record.

Follow-up

Safety and adverse events will be measured through study completion, which is an average of 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.